Experts believe that these reimbursements will begin to gain steam as more organizations turn to AI to help address some of healthcare’s biggest pain points, such as staffing shortages.
Dose reduction protocols vary across scanners and organizations. This can create inconsistencies in both image quality and measuring patients’ total radiation exposure.
Reducing certain treatments by around 25% and 50% still achieves promising PSA response rates, but reduces some of the unwanted side effects of therapy, like dry mouth.
HeartFlow is using SCCT 2024 to introduce the world to its updated Plaque Analysis platform. “Accurately diagnosing a patient’s risk for coronary artery disease is critical for determining the best treatment," Chief Medical Officer Campbell Rogers, MD, explained.
The new images were captured at the European Synchrotron Radiation Facility using hierarchical phase-contrast tomography. One specialist called them "Google Earth for the human heart."
